Keyphrases
Parkinson
81%
Parkinson's Disease
57%
GBA1
50%
Xanthine
40%
Dopaminergic Pathway
40%
Levodopa-induced Dyskinesia
40%
Cardiovascular History
40%
Disease Duration
40%
Long-read Sequencing
40%
Major Risk Factors
40%
Risk Variant
40%
Luxembourgish
40%
Pathogenic Variants
20%
Family History
20%
Non-carriers
20%
Confidence Interval
16%
Polygenic Risk Score
10%
Leucine-rich Repeat Kinase 2 (LRRK2)
10%
Enriched Pathways
10%
Boolean Modeling
10%
Cardiovascular Dysautonomia
8%
Transmission Route
6%
Dopaminergic Transmission
6%
Reduced Time
6%
Transcriptomic Network
5%
Integrated Metabolomics
5%
Global Pathway
5%
Plasma Metabolic Profiling
5%
Network Relationships
5%
Adenosine Triphosphate
5%
Pharmaceutical Targets
5%
MicroRNA s
5%
Analysis Simulation
5%
Transcription Factor EB
5%
Target Simulation
5%
Pathway Dynamics
5%
Medicine and Dentistry
Parkinson's Disease
81%
Mild Cognitive Impairment
40%
Gut Microbiome
40%
microRNA
40%
Progressive Supranuclear Palsy
40%
Observational Study
40%
Cardiovascular System
40%
Cardiovascular Disease
23%
Unified Parkinson's Disease Rating Scale
11%
Myelodysplastic Syndrome
11%
Odds Ratio
10%
Diseases
9%
Autonomic Dysfunction
5%
Dysautonomia
5%
Cardiovascular System
5%
Neuroscience
Parkinson's Disease
100%
Progressive Supranuclear Palsy
40%
MicroRNA
40%
Dyskinesia
40%
L-DOPA
40%
Mild Cognitive Impairment
40%
Dysautonomia
11%
Dopaminergic
7%
Non-Motor Symptoms
5%
Cardiovascular System
5%
